UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Interaction of platelet factor 4 with fibroblast growth factor 2 is stabilised by heparan sulphate

The international journal of biochemistry & cell biology, 2003-07, Vol.35 (7), p.1052-1055

2003

Volltextzugriff (PDF)

Modeling and Rescue of RP2 Retinitis Pigmentosa Using iPSC-Derived Retinal Organoids

Stem cell reports, 2020-07, Vol.15 (1), p.67-79

2020

Volltextzugriff (PDF)

SARM1 Ablation Is Protective and Preserves Spatial Vision in an In Vivo Mouse Model of Retinal Ganglion Cell Degeneration

International journal of molecular sciences, 2022-01, Vol.23 (3), p.1606

2022

Volltextzugriff (PDF)

AAV-NDI1 Therapy Provides Significant Benefit to Murine and Cellular Models of Glaucoma

International journal of molecular sciences, 2024-08, Vol.25 (16), p.8876

2024

Volltextzugriff (PDF)

RPE-Directed Gene Therapy Improves Mitochondrial Function in Murine Dry AMD Models

International journal of molecular sciences, 2023-02, Vol.24 (4), p.3847

2023

Volltextzugriff (PDF)

Suppression and Replacement Gene Therapy for Autosomal Dominant Disease in a Murine Model of Dominant Retinitis Pigmentosa

Molecular therapy, 2011-04, Vol.19 (4), p.642-649

2011

Volltextzugriff (PDF)

AAV-PHP.eB transduces both the inner and outer retina with high efficacy in mice

Molecular therapy. Methods & clinical development, 2022-06, Vol.25, p.236-249

2022

Volltextzugriff (PDF)

Novel 199 base pair NEFH promoter drives expression in retinal ganglion cells

Scientific reports, 2020-10, Vol.10 (1), p.16515-16515, Article 16515

2020

Volltextzugriff (PDF)

Toward an elucidation of the molecular genetics of inherited retinal degenerations

Human molecular genetics, 2017-08, Vol.26 (R1), p.R2-R11

2017

Volltextzugriff (PDF)

CHD5 Is Required for Neurogenesis and Has a Dual Role in Facilitating Gene Expression and Polycomb Gene Repression

Developmental cell, 2013-08, Vol.26 (3), p.223-236

2013

Volltextzugriff (PDF)

Optimized OPA1 Isoforms 1 and 7 Provide Therapeutic Benefit in Models of Mitochondrial Dysfunction

Frontiers in neuroscience, 2020-11, Vol.14, p.571479-571479

2020

Volltextzugriff (PDF)

AAV-Delivered Tulp1 Supplementation Therapy Targeting Photoreceptors Provides Minimal Benefit in Tulp1−/− Retinas

Frontiers in neuroscience, 2020-08, Vol.14

2020

Volltextzugriff (PDF)

Mitochondrial disorders: aetiologies, models systems, and candidate therapies

Trends in genetics, 2013-08, Vol.29 (8), p.488-497

2013

Volltextzugriff (PDF)

A Novel Retinal Ganglion Cell Promoter for Utility in AAV Vectors

Frontiers in neuroscience, 2017-09, Vol.11, p.521-521

2017

Volltextzugriff (PDF)

Efficacy of codelivery of dual AAV2/5 vectors in the murine retina and hippocampus

Human gene therapy, 2012-08, Vol.23 (8), p.847-858

2012

Volltextzugriff (PDF)

Cell therapy using retinal progenitor cells shows therapeutic effect in a chemically-induced rotenone mouse model of Leber hereditary optic neuropathy

European journal of human genetics : EJHG, 2014-11, Vol.22 (11), p.1314-1320

2014

Volltextzugriff (PDF)

Optimisation of AAV-NDI1 Significantly Enhances Its Therapeutic Value for Correcting Retinal Mitochondrial Dysfunction

Pharmaceutics, 2023-01, Vol.15 (2), p.322

2023

Volltextzugriff (PDF)

RNA Interference–Mediated Suppression and Replacement of Human Rhodopsin In Vivo

American journal of human genetics, 2007-07, Vol.81 (1), p.127-135

2007

Volltextzugriff (PDF)

Retinal Bioenergetics: New Insights for Therapeutics

Advances in experimental medicine and biology, 2019, Vol.1185, p.275-279

2019

Volltextzugriff (PDF)

AAV‐mediated gene therapy improving mitochondrial function provides benefit in age‐related macular degeneration models

Clinical and translational medicine, 2022-08, Vol.12 (8), p.e952-n/a

2022

Volltextzugriff (PDF)

microRNA regulatory circuits in a mouse model of inherited retinal degeneration

Scientific reports, 2016-08, Vol.6 (1), p.31431, Article 31431

2016

Volltextzugriff (PDF)

Improved Retinal Function in a Mouse Model of Dominant Retinitis Pigmentosa Following AAV-delivered Gene Therapy

Molecular therapy, 2009-04, Vol.17 (4), p.593-599

2009

Volltextzugriff (PDF)

Adeno-associated virus-mediated rhodopsin replacement provides therapeutic benefit in mice with a targeted disruption of the rhodopsin gene

Human gene therapy, 2010-03, Vol.21 (3), p.311-323

2010

Volltextzugriff (PDF)

Intravitreal delivery of AAV-NDI1 provides functional benefit in a murine model of Leber hereditary optic neuropathy

European journal of human genetics : EJHG, 2013-01, Vol.21 (1), p.62-68

2013

Volltextzugriff (PDF)

AAV-mediated chronic over-expression of SNAP-25 in adult rat dorsal hippocampus impairs memory-associated synaptic plasticity

Journal of neurochemistry, 2010-02, Vol.112 (4), p.991-1004

2010

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(38)
Dissertationen
(1)

Sprache

Englisch
(39)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Interaction of platelet factor 4 with fibroblast growth factor 2 is stabilised by heparan sulphate

Modeling and Rescue of RP2 Retinitis Pigmentosa Using iPSC-Derived Retinal Organoids

SARM1 Ablation Is Protective and Preserves Spatial Vision in an In Vivo Mouse Model of Retinal Ganglion Cell Degeneration

AAV-NDI1 Therapy Provides Significant Benefit to Murine and Cellular Models of Glaucoma

RPE-Directed Gene Therapy Improves Mitochondrial Function in Murine Dry AMD Models

Suppression and Replacement Gene Therapy for Autosomal Dominant Disease in a Murine Model of Dominant Retinitis Pigmentosa

AAV-PHP.eB transduces both the inner and outer retina with high efficacy in mice

Novel 199 base pair NEFH promoter drives expression in retinal ganglion cells

Toward an elucidation of the molecular genetics of inherited retinal degenerations

CHD5 Is Required for Neurogenesis and Has a Dual Role in Facilitating Gene Expression and Polycomb Gene Repression

Optimized OPA1 Isoforms 1 and 7 Provide Therapeutic Benefit in Models of Mitochondrial Dysfunction

AAV-Delivered Tulp1 Supplementation Therapy Targeting Photoreceptors Provides Minimal Benefit in Tulp1−/− Retinas

Mitochondrial disorders: aetiologies, models systems, and candidate therapies

A Novel Retinal Ganglion Cell Promoter for Utility in AAV Vectors

Efficacy of codelivery of dual AAV2/5 vectors in the murine retina and hippocampus

Cell therapy using retinal progenitor cells shows therapeutic effect in a chemically-induced rotenone mouse model of Leber hereditary optic neuropathy

Optimisation of AAV-NDI1 Significantly Enhances Its Therapeutic Value for Correcting Retinal Mitochondrial Dysfunction

RNA Interference–Mediated Suppression and Replacement of Human Rhodopsin In Vivo

Retinal Bioenergetics: New Insights for Therapeutics

AAV‐mediated gene therapy improving mitochondrial function provides benefit in age‐related macular degeneration models

microRNA regulatory circuits in a mouse model of inherited retinal degeneration

Improved Retinal Function in a Mouse Model of Dominant Retinitis Pigmentosa Following AAV-delivered Gene Therapy

Adeno-associated virus-mediated rhodopsin replacement provides therapeutic benefit in mice with a targeted disruption of the rhodopsin gene

Intravitreal delivery of AAV-NDI1 provides functional benefit in a murine model of Leber hereditary optic neuropathy

AAV-mediated chronic over-expression of SNAP-25 in adult rat dorsal hippocampus impairs memory-associated synaptic plasticity

Suchergebnisse filtern